Capital Raising & Corporate Finance
When’s A Good Time To IPO?
The excitement of going public is returning as corporates find moxie and roll the dice.
Author: Anthony Noto
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click Here
Economics, Policy & Regulation
China Tells Intel ‘No’
President Joe Biden’s recent decision to ban US companies from making new investments in Chinese technology prompted the Chinese government to respond in kind by blocking Intel's acquisition of Tower Semiconductor.
Economics, Policy & Regulation
American Credit Card Debt Continues To Climb
Consumers are using credit cards more than ever but delinquency rates haven't increased—for now.
Capital Raising & Corporate Finance
What’s Spiking Sport Team Valuations? Q&A With Citi Head Of Sports Finance Ivo Voynov
Citi Private Bank has advised sports deals of all kinds for some 25 years. Ivo Voynov, who joined the firm in September from rival JPMorgan Chase & Co., talks to Global Finance about why the sector is attracting so much interest.
News
Blackrock Bets On Bitcoin ETF
Until now, the SEC has only approved bitcoin-futures-based ETFs even though industry insiders contend they are riskier than bitcoin ETFs.
Capital Raising & Corporate Finance
IPOs: Offerings Keep Trickling In
Sticky inflation, interest rate hikes, and Russia’s ongoing war in Ukraine are among the factors that will continue to chill IPO prospects.
Capital Raising & Corporate Finance
PGA Tour Board Member Pleads with Colleagues: Reconsider Saudi Deal
Just as the US Senate prepares to talk golf on Capitol Hill, one PGA exec is urging his fellow directors to “evaluate alternative sources of capital.”
Capital Raising & Corporate Finance
Qatar’s Purchase Of Manchester United Stalls Due To Family Drama
Upheaval among the football club’s owners, and angry fans, puts a $6 billion-plus deal at stake.
Capital Raising & Corporate Finance
Nasdaq’s $10 Billion RegTech Deal Shows Urgency, Cost Of Compliance
Corporates are wielding M&A to scoop up the tech they need in order to keep up with strict rules and regulations.
Capital Raising & Corporate Finance
Saudi Arabia’s Middle America Makeover
Profit overrides principle with the recent PGA-LIV Golfdeal; expect more M&A in sports and other sectors.
Capital Raising & Corporate Finance
Pharmaceutical Giant Sees Largest-Ever Bond Sale
Pfizer’s eight tranches of notes, priced from $3 billion to $6 billion each, will mature between 2025 and 2063.
Capital Raising & Corporate Finance
Multinationals Get Squeezed By FX Volatility
North American industries most affected by currency exposure were professional services, biotech and pharmaceuticals, machinery, trading and distribution, chemicals and health equipment and supplies.